Use of inpatient systemic chemotherapy and/or radiotherapy and related predictive factors, healthcare resource utilization, and direct hospitalization costs for metastatic urothelial cancer: findings from a real-world retrospective observational study derived from the national hospital discharge claims database in Italy

Use of inpatient systemic chemotherapy and/or radiotherapy and related predictive factors, healthcare resource utilization, and direct hospitalization costs for metastatic urothelial cancer: findings from a real-world retrospective observational study derived from the national hospital discharge claims database in Italy

Abstract Background Recent real-world studies revealed high proportions of patients with metastatic urothelial cancer (mUC) do not receive any systemic therapy. This study describes the demographics, clinical characteristics, treatment rate and related predictive factors, healthcare resource utiliza...

Full description

Saved in:
Bibliographic Details
Main Authors: Mairead Kearney, Melissa Kirker, Allison Thompson, Norbek Gharibian, Martina Furegato, Cécile Pacheco, Seham Issa, Reyhan Hasanova, Paolo Sciattella, Matteo Scortichini, Francesco Saverio Mennini
Format: Article
Language:English
Published: BMC 2024-11-01
Series:BMC Cancer
Subjects:
Urothelial cancer
Metastatic
Treatment rate
Predictive factors
HCRU
Costs
Online Access:https://doi.org/10.1186/s12885-024-13075-y
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items

Similar Items